Mark Brister Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Brister.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Brister. Mark Brister is a VP Advanced Development Teams in DEXCOM INC ($DXCM) and a Chief Technology Officer in OBALON THERAPEUTICS INC ($OBLN) and a VP of Research and Development in OBALON THERAPEUTICS INC ($OBLN).
Address: C/O DEXCOM, INC. 5555 OBERLIN DRIVE SAN DIEGO 92121 CA
Companies in which Mark Brister is an Insider
DEXCOM INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Mark Brister: VP Advanced Development Teams
Holdings: 10,967 shares
Current Value: $873,741
Latest Transaction: May 04 2006
$DXCM Market Capitalization: $6.75B
$DXCM Previous Close: $79.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ReShape Lifesciences Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Mark Brister: Chief Technology Officer, VP of Research and Development
Holdings: 38,865 shares
Current Value: $371,549
Latest Transaction: Oct 28 2019
$OBLN Market Capitalization: $158.66M
$OBLN Previous Close: $9.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Brister
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28 2019 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Option Exercise | A | 1.75 | 13,000 | 22,750 | 13,000 | |
| Oct 28 2019 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Option Exercise | A | 1.75 | 13,000 | 22,750 | 13,000 | |
| Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Option Exercise | P | 4.40 | 3,750 | 16,500 | 3,750 | |
| Aug 08 2019 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Buy | P | 4.00 | 5,000 | 20,000 | 38,865 | 33.9 K to 38.9 K (+14.76 %) |
| Jul 25 2019 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Option Exercise | A | 0.96 | 35,000 | 33,600 | 35,000 | |
| Jan 04 2019 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Option Exercise | A | 2.30 | 100,000 | 230,000 | 100,000 | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Grant | A | 1.82 | 107,142 | 194,998 | 338,634 | 231.5 K to 338.6 K (+46.28 %) |